Related Funds
Fund Name | Location |
Caron Brothers Investments 2, LLC | - |
Cypher Holdings | - |
Genesys Partners | New York, New York, United States |
Horry Telephone Cooperative | Myrtle Beach, South Carolina, United States |
Innovate Angel Funds | College Station, Texas, United States |
Life Science Angels | California, Sunnyvale, United States |
Media Chinese International | China, Hong Kong, Hong Kong Island |
Metrocall | Alexandria, United States, Virginia |
Newmont | Colorado, Denver, United States |
Nidus Partners | Missouri, St Louis, United States |
Nobska Point Capital | Boston, Massachusetts, United States |
Panasonic Information Systems | Japan, Osaka, Osaka Prefecture |
Schroeder & Co | - |
Seed X Liechtenstein | Liechtenstein, Schaan, Schaan |
Suda Tiangong | China, Jiangsu, Suzhou |
Takura Capital | Harare, Harare, Zimbabwe |
The Emerson Group | Pennsylvania, United States, Wayne |
Timentor | China, Liaoning, Shenyang |
William Blair New World Ventures | Chicago, Illinois, United States |
Woodford Investment Management | Oxford, Oxfordshire, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
FluoRok | 23 Sep 2024 | Oxford, Oxfordshire, United Kingdom | |||
Beacon Therapeutics | $170M | 03 Jun 2024 | London, England, United Kingdom | ||
Oxford Endovascular | $10M | 20 May 2024 | Oxford, England, United Kingdom | ||
Navenio | $6M | 20 Sep 2023 | Oxford, England, United Kingdom | ||
OXCCU | $22M | 07 Jun 2023 | Oxford, Oxfordshire, United Kingdom | ||
Pepgen | $45M | 09 Dec 2020 | Oxford, England, United Kingdom | ||
Refeyn | $30M | 11 Nov 2020 | Oxford, England, United Kingdom | ||
Navenio | $13M | 20 May 2020 | Oxford, England, United Kingdom | ||
Perspectum | $35M | 14 Apr 2020 | Oxford, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
FluoRok | 23 Sep 2024 | Oxford, Oxfordshire, United Kingdom | |||
Beacon Therapeutics | $170M | 03 Jun 2024 | London, England, United Kingdom | ||
Oxford Endovascular | $10M | 20 May 2024 | Oxford, England, United Kingdom | ||
Navenio | $6M | 20 Sep 2023 | Oxford, England, United Kingdom | ||
OXCCU | $22M | 07 Jun 2023 | Oxford, Oxfordshire, United Kingdom | ||
Pepgen | $45M | 09 Dec 2020 | Oxford, England, United Kingdom | ||
Refeyn | $30M | 11 Nov 2020 | Oxford, England, United Kingdom | ||
Navenio | $13M | 20 May 2020 | Oxford, England, United Kingdom | ||
Perspectum | $35M | 14 Apr 2020 | Oxford, England, United Kingdom |